Financials

  • Market Capitalization 8.26 B
  • Employee 399
  • Founded 1993
  • CEO Michael S Weiss
  • Website www.tgtherapeutics.com
  • Headquarter Delaware, United States
  • FIGI BBG000FVZQY1
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
10.76
市销率
7.81

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
1014
IMVT
Immunovant, Inc. - Common Stock
41.20 USD-5.98%-6.36%+6.71%+114.47%8.51 B USD
1024
APGE
Apogee Therapeutics, Inc. - Common Stock
134.97 USD+0.01%+0.13%+0.54%+151.86%8.40 B USD
1057
SYRE
Spyre Therapeutics, Inc. - Common Stock
90.36 USD-3.48%-15.15%-8.04%+277.92%7.97 B USD
1090
RYTM
Rhythm Pharmaceuticals, Inc. - Common Stock
107.17 USD-4.76%-4.56%+1.60%-2.85%7.38 B USD

新闻